Publications

Shastri A, Daver NG, Hayes TG. Primary Gastric Chorioadenocarcinoma: A case report and review of literature.
Rare Tumors. 2011 Apr, PMID: 21769318

Cooperman,N; Shastri JS; Shastri, A; Schoenbaum, E; HIV Prevalence, Risk Behavior, Knowledge and Beliefs among Women Seeking Care at a Sexually Transmitted Infection Clinic in Mumbai, India.
Health Care Women Int. 2013 Mar 4, PMID: 23659311

Daver N, Shastri A, Kadia T, Quintas-Cardama A, Jabbour E, Konopleva M, O'Brien S, Pierce S, Zhou L, Cortes J, Kantarjian H, Verstovsek S. Modest activity of pomalidomide in patients with myelofibrosis and significant anemia. Leukemia Research. 2013 Jul 24, PMID: 23890523

Murthy SB, Karanth S, Shah S, Shastri A, Venkatasubba Rao CP, Bershad E, Suarez JI. Thrombolysis for Acute Ischemic Stroke in Patients with Cancer: A Population Study.
Stroke. 2013 Dec; PMID : 2406571

Murthy SB, Moradiya Y, Shah S, Shastri A, Bershad E, Suarez JI. In-hospital Outcomes of Thrombolysis for Acute Ischemic Stroke in Patients with Primary Brain Tumors.
Journal of Clinical Neuroscience. 2014. PMID : 25564270

Shusterman M, Bloomgarden NA, Sotardi ST, Shastri A. Tumor Lysis Syndrome in an Unusual Metastatic Pancreatic Neuroendocrine Tumor with Ectopic ACTH Secretion.
J Gastrointest Cancer. 2015 Aug 14, PMID : 26271662

Daver N,* Shastri A,* Kadia T, Quintas-Cardama A, Pemmaraju N, Jabbour E, Konopleva M, O’Brien S, Pierce S, Cortes J, Kantarjan H, Verstovsek S. Phase II study of pomalidomide in combination with prednisone in patients with myelofibrosis and significant anemia.
Leukemia Research 2014 Jul, PMID: 25047979 * Equally Contributed

Shastri A, Shastri SS. Cancer screening and prevention in low-resource environments.
Nature Reviews Cancer, 2014 Dec; PMID: 25355377

Schinke, C, Giricz O, Li W, Shastri A, Gordon S, Barreyro L, Bhagat T, Bhattacharya S, Will B, Steidl U, Verma A. IL-8/CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells,
Blood, 2015 Mar, PMID: 25810490

Shastri A, Msaouel P, Montagna C, White S, Delio M, Patel K, Alexis K, Strakhan M, Elrafei T, Reed LJ. Primary hepatic small cell carcinoma: two case reports, molecular characterization and a pooled analysis of known clinical data.
Anticancer Res. 2016 Jan, PMID: 26722053

Assal A, Dong B, Khan H, Medavarapu R, Shastri A, Pradhan K, Friedman E, Mantzaris I, Janakiram M, Battini R, Kornblum N, Yu Y, Verma A, Braunschweig I, Derman O. Analysis of chronic myelogenous leukemia in an underserved, inner-city cohort shows a significant five year overall survival that is not affected by choice of tyrosine kinase inhibitor. Leukemia Lymphoma. 2016 Feb 17:1-4. PMID:26886689

Bachegowda L, Morrone K, Winski SL, Mantzaris I, Bartenstein M, Ramachandra N, Giricz O, Sukrithan V, Nwankwo G, Shahnaz S, Bhagat TD, Bhattacharyya S, Assal A, Shastri A, Gordon-Mitchell S, Pellagatti A, Boultwood J, Schinke C, Yu Y, Guha C, Rizzi J, Garrus J, Brown S, Wollenberg L, Hogeland G, Wright D, Munson M, Rodriguez M, Gross S, Chantry D, Zou Y, Platanias LC, Burgess LE, Pradhan K, Steidl U, Verma A. Pexmetinib : A Novel Dual Inhibitor of Tie2 and p38MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes & Acute Myeloid Leukemia. Cancer Res. 2016 Aug 15. PMID : 27287719

Zell M, Assal A, Derman O, Kornblum N, Battini R, Wang Y, Narasimhulu DM, Mantzaris I, Shastri A, Verma A, Ye H, Braunschweig I, Janakiram M. Adult T-Cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy.
Oncotarget. 2016 Jun 22. PMID:27341021

Goel S, Hall J, Pradhan K, Hirsch C, Przychodzen B, Shastri A, Mantzaris I, Janakiram M, Battini R, Kornblum N, Derman O, Gritsman K, Al-Hafidh J, Wang Y, Halmos B, Steidl U, Maciejewski JP, Braunschweig I, Verma A. High prevalence and allele burden-independent prognostic importance of p53 mutations in an inner-city MDS/AML cohort.
Leukemia. 2016 Aug;30. PMID :27125205

Murthy SB, Shastri A, Merkler AE, Hanley DF, Ziai WC, Fink ME, Iadecola C, Kamel H, Navi BB. Intracerebral Hemorrhage Outcomes in Patients with Systemic Cancer.
J Stroke Cerebrovasc Dis. 2016 Aug 25. PMID: 27569708

Shastri A; Will B; Steidl U; Verma A. Stem Cell Alterations In Myelodysplastic Syndromes. Blood, 2017 Feb, PMID: 28159737

Shastri A; Budhathoki A; Barta S; Kornblum N; Derman O; Battini R; Raghupathy R; Verma A; Frenette P; Braunschweig I; Janakiram M. Stimulation of Adrenergic Activity by Desipramine Enhances Hematopoietic Stem and Progenitor Cell Mobilization along with G-CSF in Multiple Myeloma. Am J Hematol. 2017 Jul 4. PMID: 28675459

Shastri A; Mantaris I; Yu Y; Janakiram M; Verma A; Barta SK. Sites of Extranodal Invovlement Are Prognostic I n Patients with Stage 1 Follicular Lymphoma: An Analysis of the Surveillance, Epidemiology and End Results Database. Oncotarget. 2017 Jul 14. PMID: 29108238

Darbinyan K*; Shastri, A*; Budhathoki, A*; Helbig, D; Pradhan K et all. Hispanic Ethnicity is Associated with Younger Age at Presentation and Worse Survival in Acute Myeloid Leukemia. Blood Advances. * Equally Contributed 2017 Oct. PMID: 29296859

Kanna S; Choudhary G; Ramachandran N; Steidl U; Verma AK; Shastri A. STAT3 inhibition as a therapeutic strategy for leukemia. Leuk Lymphoma. 2017 Nov 22. PMID : 29164994

Shastri A; Verma A; Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML. Lancet Haematology. Jan 2018, PMID : 29241763

Snyder R, Libby T, Raciti P, Amin B, Jacobson M, Rakheja D, Fleming K, Bartenstein M, Zhu C, Goel S, Verma AK, Shastri A. Myelodysplastic Syndrome and Sweets Syndrome Are Associated with a Mutation in Isocitrate Dehydrogenase 1. Anticancer Research. April 2018, PMID : 29599340

Adrianzen Herrera D, Ayyappan S, Jasra S, Kornblum N, Derman O, Shastri A, Mantzaris I, Verma A, Braunschweig I, Janakiram M. Characteristics and outcomes of progressive multifocal leukoencephalopathy in hematologic malignancies and stem cell transplant - a case series. Leukemia Lymphoma, July 2018, PMID: 29969336

Shah UA, Chung EY, Giricz O, Pradhan K, Kataoka K, Gordon-Mitchell S, Bhagat TD, Mai Y, Wei Y, Ishida E, Choudhary GS, Joseph A, Rice R, Gitego N, Parrish C, Bartenstein M, Goel S, Mantzaris I, Shastri A, Derman O, Binder A, Gritsman K, Kornblum N, Braunschweig I, Bhagat C, Hall J, Graber A, Ratner L, Wang Y, Ogawa S, Verma A, Ye BH, Janakiram M. North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies. Blood, Aug 2018, PMID: 30104217

Kao YR, Chen J, Narayanagari SR, Todorova TI, Aivalioti MM, Ferreira M, Ramos PM, Pallaud C, Mantzaris I, Shastri A, Bussel JB, Verma A, Steidl U, Will B. Thrombopoietin receptor-independent stimulation of hematopoietic stem cells by eltrombopag. Science Translational Medicine. Sept 2018. PMID : 30209246

Shastri A, Choudhary G, Teixeira M, Gordon-Mitchell S, Ramachandra N, Bernard L, Bhattacharyya S, Lopez R, Pradhan K, Giricz O, Ravipati G, Wong L, Cole S, Bhagat T, Feld J, Dhar Y, Bartenstein M, Thiruthuvanathan V, Wickrema A, Ye H, Frank D, Pellagatti A, Boultwood J, Zhou T, Kim Y, MacLeod R,Epling-Burnette PK, Ye M, McCoon P, Woessner R, Steidl U, Will B and Verma A. Antisense STAT3 Inhibitor Decreases Viability of Myelodysplastic and Leukemic Stem Cells. Journal of Clinical Investigation, Dec 2018, PMID : 30252677

Adrianzen Herrera D, Kornblum N, Acuna-Villaorduna A, Sica RA, Shah U, Butler M, Vishnuvardhan N, Shah N, Bachier-Rodriguez L, Derman O, Shastri A, Mantzaris I, Verma AK, Braunschweig I, Janakiram M. Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1-Associated Adult T Cell Lymphoma-Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary Center. Biol Blood Marrow Transplant. Feb 2019. PMID : 30769194

Kaner JD, Thibaud S, Jasra S, Wang Y, Janakiram M, Sharma A, Sridharan A, Elias H, Polineni R, Assal A, Weiss L, Braunschweig I, Steidl U, Pradhan K, Shastri A, Chaitowitz M, Zingman B, Will B, Mantzaris I, Verma A. HIV portends a poor prognosis in myelodysplastic syndromes. Leukemia Lymphoma. 2019 Dec. PMID : 3128224

Acuna-Villaorduna A, Gonzalez-Lugo J, Ye BH, Adrianzen Herrera DA, Sica RA, Shah U, Shah N, Kornblum N, Braunschweig I, Derman O, Mantzaris I, Shastri A, Wang Y, Verma A, Zalta B, Janakiram M. High prevalence of pulmonary findings in computed tomographies of HTLV-1-infected patients with and without adult-T cell leukemia/lymphoma - implications for staging. Leuk Lymphoma. 2019 Dec. PMID: 31204876

Bowler TG, Pradhan K, Kong Y, Bartenstein M, Morrone KA, Sridharan A, Kessel RM, Shastri A, Giricz O, Bhagat TD, Gordon-Mitchell S, Rohanizadegan M, Hooda L, Datt I, Przychodzen BP, Parmar S, Maqbool S, Maciejewski JP, Steidl U, Greally JM, Verma A. Misidentification of MLL3 and other mutations in cancer due to highly homologous genomic regions. Leukemia Lymphoma 2019 Dec 1PMID: 31288594

Shah UA, Shah N, Qiao B, Acuna-Villaorduna A, Pradhan K, Adrianzen Herrera D, Sica RA, Shastri A, Mantzaris I, Derman O, Kornblum N, Braunschweig I, Ye BH, Verma A, Janakiram M. Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United States. Cancer 2020 Feb 1. PMID: 31769871

Sridharan A, Schinke CD, Georgiev G, Da Silva Ferreira M, Thiruthuvanathan V, MacArthur I, Bhagat TD, Choudhary GS, Aluri S, Chen J, Pradhan K, Xia Y, Panjikaran M, Sims G, Bhagat CK, Bender R, Keeler L, Graber A, Heuck C, Fletcher FA, Alapat D, Weinhold N, Johnson SK, Wickrema A, Barlogie B, Morgan GJ, Shastri A, Steidl U, Will B, Verma A. Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias. Blood Advances. 2019 Dec 10; PMID : 31805192

Adrianzen Herrera D, Pradhan K, Snyder R, Karanth S, Janakiram M, Mantzaris I, Braunschweig I, Budhathoki A, Shah UA, Verma AK, Murthy SB, Shastri A. Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis.Leukemia. 2019 Dec 16. PMID : 31844145

Abbasi A, Peeke S, Shah N, Mustafa J, Khatun F, Lombardo A, Abreu M, Elkind R, Fehn K, de Castro A, Wang Y, Derman O, Nelson R, Uehlinger J, Gritsman K, Sica RA, Kornblum N, Mantzaris I, Shastri A, Janakiram M, Goldfinger M, Verma A, Braunschweig I, Bachier-Rodriguez L. Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis.
J Hematol Oncol. 2020 Jan. PMID: 31900191

Gonzalez-Lugo JD, Bachier-Rodriguez L, Goldfinger M, Shastri A, Sica RA, Gritsman K, Mehta V, Kabarriti R, Goel S, Verma A, Braunschweig I, Kornblum N, Mantzaris I. A case series of Monoclonal Gammopathy of Undetermined Significance and COVID-19.
Br J Haematol. 2020 Aug; PMID: 32479664

Adrianzen-Herrera D, Choudhary G, Gordon-Mitchell S, Ramachandra N, Bhagat T, Zhang H, Aluri S, Shastri A, Steidl U, Will B, Yang WL, Mahler M, Eichenbaum G, Guha C, Verma A. Leuk Lymphoma. The thrombopoietin mimetic JNJ-26366821 increases megakaryopoiesis without affecting malignant myeloid proliferation.
Leuk Lymphoma 2020 Oct PMID: 32578476

Shah N, Rockwell B, Kazemi M, Peeke S, Bachier-Rodriguez L, Sica RA, Goldfinger M, Kornblum N, Braunschweig I, Shastri A, Verma A, Mantzaris I. Ethnic disparities in survival of adult B-cell acute lymphoblastic leukemia in modern era - a SEER analysis.
Leuk Lymphoma. 2020. PMID: 32960113

Shastri A, Lugo-Gonzalez J, Verma A. Understanding FLT3 Inhibitor Resistance to Rationalize Combinatorial AML Therapies. Blood Cancer Discov. 2020 Dec. PMID :34661152

Kaur G, Mejia Saldarriaga M, Shah N, Catamero DD, Yue L, Ashai N, Goradia N, Heisler J, Xiao Z, Ghalib N, Aaron T, Cole D, Foreman R, Mantzaris I, Derman O, Bachier L, Sica RA, Kornblum N, Braunschweig I, Shastri A, Goel S, Verma A, Janakiram M. Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry Data. Clin Lymphoma Myeloma Leuk. 2020 Nov 21. PMID: 33339770

Lugo-Gonzalez J, Chakraborty S, Verma A, Shastri A. The Evolution of Epigenetic Therapy in Myelodysplastic Syndromes & Acute Myeloid Leukemia. Seminars in Hematology. Dec 2020. PMID : 33509444

Jasra S, Kazemi M, Shah N, Chen J, Fehn K, Wang Y, Mantzaris I, Kornblum N, Sica A, Bachier L, Goldfinger M, Gritsman K, Braunschweig I, Steidl U, Shastri A, Verma A.
Exp Hematol Oncol. 2021 Jan. Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML. PMID : 33397455

Shapiro LC, Mustafa J, Lombardo A, Khatun F, Joseph F, Gillick K, Naik A, Elkind R, Abreu M, Fehn K, de Castro A, Pradhan K, Binakaj D, Nelson R, Paroder M, Uehlinger J, Gritsman K, Alejandro Sica R, Kornblum N, Shastri A, Mantzaris I, Bachier-Rodriguez L, Verma A, Braunschweig I, Goldfinger M. Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population. Bone Marrow Transplant. 2021 Jul. PMID : 33846558

Chakraborty S, Shapiro LC, de Oliveira S, Rivera-Pena B, Verma A, Shastri A. Therapeutic targeting of the inflammasome in myeloid malignancies. Blood Cancer J. 2021 Sep 14. PMID: 34521810

Rahmani, N et all. ASXL1 Mutations Are Associated with Distinct Epigenomic Alterations that Lead to Sensitivity to Venetoclax and Azacytidine. Blood Cancer J. 2021 Sep. PMID : PMID: 34548471

Shastri A, Adrianzen-Herrera DA. Ruxolitinib in CMML: A Case Study of Innovative Trial Design in a Rare Cancer. Clin Cancer Res. 2021 Nov. PMID : 34531297

Zavras PD, Shastri A, Goldfinger M, Verma AK, Saunthararajah Y.Clinical Trials Assessing Hypomethylating Agents Combined with Other Therapies: Causes for Failure and Potential Solutions.Clin Cancer Res. 2021 Dec 15. PMID: 34551907

Thakkar A, Cui Z, Peeke SZ, Shah N, Pradhan K, Lombardo A, Khatun F, Mustafa J, De Castro A, Gillick K, Joseph F, Naik A, Rahman S, D'Aiello A, Elkind R, Sakalian S, Fehn K, Wright K, Abreu M, Townsend-Nugent L, Chambers N, Mathew R, Binakaj D, Nelson R, Palesi C, Paroder M, Uehlinger J, Wang Y, Shi Y, Zang X, Wang H, Nishimura C, Ren X, Steidl UG, Gritsman K, Janakiram M, Kornblum N, Derman O, Mantzaris I, Shastri A, Bartash R, Puius Y, McCort M, Goldfinger M, Bachier-Rodriguez L, Verma A, Braunschweig I, Sica RA. Patterns of leukocyte recovery predict infectious complications after CD19 CAR-T cell therapy in a real-world setting. Stem Cell Investig. 2021 Sep . PMID : 34631871

Rabinovich E, Pradhan K, Sica RA, Bachier-Rodriguez L, Mantzaris I, Kornblum N, Shastri A, Gritsman K, Goldfinger M, Verma A, Braunschweig I. Elevated LDH greater than 400 U/L portends poorer overall survival in diffuse large B-cell lymphoma patients treated with CD19 CAR-T cell therapy in a real world multi-ethnic cohort.Exp Hematol Oncol. 2021 Dec. PMID: 34886908

Jasra S, Giricz O, Zeig-Owens R, Pradhan K, Goldfarb DG, Barreto-Galvez A, Silver AJ, Chen J, Sahu S, Gordon-Mitchell S, Choudhary GS, Aluri S, Bhagat TD, Shastri A, Bejan CA, Stockton SS, Spaulding TP, Thiruthuvanathan V, Goto H, Gerhardt J, Haider SH, Veerappan A, Bartenstein M, Nwankwo G, Landgren O, Weiden MD, Lekostaj J, Bender R, Fletcher F, Greenberger L, Ebert BL, Steidl U, Will B, Nolan A, Madireddy A, Savona MR, Prezant DJ, Verma A. High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster. Nat Med 2022 Mar;28. PMID: 35256801

Rubinstein SM, Bhutani D, Lynch RC, Hsu CY, Shyr Y, Advani S, Mesa RA, Mishra S, Mundt DP, Shah DP, Sica RA, Stockerl-Goldstein KE, Stratton C, Weiss M, Beeghly-Fadiel A, Accordino M, Assouline SE, Awosika J, Bakouny Z, Bashir B, Berg S, Bilen MA, Castellano CA, Cogan JC, Kc D, Friese CR, Gupta S, Hausrath D, Hwang C, Johnson NA, Joshi M, Kasi A, Klein EJ, Koshkin VS, Kuderer NM, Kwon DH, Labaki C, Latif T, Lau E, Li X, Lyman GH, McKay RR, Nagaraj G, Nizam A, Nonato TK, Olszewski AJ, Polimera HV, Portuguese AJ, Puc MM, Razavi P, Rosovski R, Schmidt A, Shah SA, Shastri A, Su C, Torka P, Wise-Draper TM, Zubiri L, Warner JL, Thompson MA; COVID-19 and Cancer Consortium. Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19. Blood Cancer Discov. 2022 May. PMID: 35262738

Zhang Y, Chen X, Wang H, Gordon-Mitchell S, Sahu S, Bhagat TD, Choudhary G, Aluri S, Pradhan K, Sahu P, Carbajal M, Zhang H, Agarwal B, Shastri A, Martell R, Starczynowski D, Steidl U, Maitra A, Verma A. Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer. J Hematol Oncol. 2022 Jul 26, PMID : 35883108

Adrianzen-Herrera D, Sparks AD, Shastri A, Zakai NA, Littenberg B. Geographic disparities in cardiovascular mortality among patients with myelodysplastic syndromes: A population-based analysis. Cancer Epidemiol. 2022 Oct. PMID : 35970010

Shapiro LC, Thakkar A, Gali R, Gonzalez-Lugo JD, Bazarbachi AH, Rahman S, Pradhan K, Fehn K, Abreu M, Kornblum N, Gritsman K, Goldfinger M, Shastri A, Mantzaris I, Braunschweig I, Halmos B, Verma A, McCort M, Bachier-Rodriguez L, Sica RA. High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination. Leuk Lymphoma. 2022 Oct. PMID: 35593019

Adrianzen-Herrera DA, Shastri A. Unrelated Allogeneic Stem Cell Transplant in Relapsed/Refractory AML: Widening the Yellow Brick Road. Clin Cancer Res. 2022 Oct 3;28(19):4167-4170. doi: 10.1158/1078-0432.CCR-22-1881. PMID: 35876635.

Okoye-Okafor UC, Javarappa KK, Tsallos D, Saad J, Yang D, Zhang C, Benard L, Thiruthuvanathan VJ, Cole S, Ruiz S, Tatiparthy M, Choudhary G, DeFronzo S, Bartholdy BA, Pallaud C, Ramos PM, Shastri A, Verma A, Heckman CA, Will B.J Exp Med. 2022 Nov 7. Megakaryopoiesis impairment through acute innate immune signaling activation by azacytidine. PMID: 36053753

Potts KS, Cameron RC, Metidji A, Ghazale N, Wallace L, Leal-Cervantes AI, Palumbo R, Barajas JM, Gupta V, Aluri S, Pradhan K, Myers JA, McKinstry M, Bai X, Choudhary GS, Shastri A, Verma A, Obeng EA, Bowman TV.Cell Rep. 2022 Dec. Splicing factor deficits render hematopoietic stem and progenitor cells sensitive to STAT3 inhibition.PMID: 36516770

Fedorov K, Jain T, Pradhan K, Mustafa J, Lombardo A, Khatun F, Joseph F, Gillick K, Naik A, Elkind R, Fehn K, De Castro A, Browne R, Abreu M, Binakaj D, Paroder M, Palesi C, Gritsman K, Sica RA, Kornblum N, Shastri A, Mantzaris I, Shah N, Verma A, Braunschweig I, Goldfinger M.Haematologica. 2022 Sep. Autologous stem cell transplantation in an older adult population. PMID: 35615933

Goradia N, Shastri A, Verma A, Feldman E, Cooper D, Konopleva M, Fox S, Gritsman K, Shah N, Mantzaris I, Braunschweig I, Kornblum N, Sica A, Levitz D, Comas M, Goldfinger M. A Co-Management Model for Myeloid Malignancies That Evolved during the COVID-19 Pandemic. Acta Haematol. 2023; Nov 29.PMID: 36446346

Gonzalez-Lugo JD, Kambhampati S, Yacoub A, Donnellan WB, Berdeja J, Bhagat P, Fehn K, Remy C, Jasra S, Kazemi M, Pradhan K, Kim M, Mantzaris I, Sica RA, Shah N, Goldfinger M, Kornblum N, Gritsman K, Braunschweig I, Steidl U, Will B, Shastri A, Verma A. Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial. Clin Cancer Res. 2023 Jan 4;29(1):60-66. doi: 10.1158/1078-0432.CCR-22-1457. PMID: 36255372.

Pophali P, Desai SR, Shastri A. Therapeutic Targets in Myelodysplastic Neoplasms: Beyond Hypomethylating Agents. Curr Hematol Malig Rep. 2023 Jun;18(3):56-67. doi: 10.1007/s11899-023-00693-9. Epub 2023 Apr 13. PMID: 37052811.

Levitz D, Saunthararajah Y, Fedorov K, Shapiro LC, Mantzaris I, Shastri A, Kornblum N, Sica RA, Shah N, Konopleva M, Gritsman K, Braunschweig I, Cooper DL, Pradhan K, Verma A, Feldman EJ, Goldfinger M. A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML. Clin Cancer Res. 2023 Jun 21:OF1-OF7. doi: 10.1158/1078-0432.CCR-23-0842. Epub ahead of print. PMID: 37341641.

Chai J, Choudhuri J, Wang Q, Fang Y, Shi Y, Kamel J, Shah N, Sica RA, Kornblum N, Konopleva M, Mantzaris I, Shastri A, Gritsman K, Verma A, Goldfinger M, Goel S, Wang Y, Tian X. Acute myeloid leukemias with JAK2/STAT mutations are associated with PD-L1 upregulation. Leuk Lymphoma. 2023 Jul 10:1-11. doi: 10.1080/10428194.2023.2232494. Epub ahead of print. PMID: 37424335.

Bazarbachi AH, Reef D, Narvel H, Patel R, Al Hamed R, Vikash S, Neupane K, Atalla E, Thakkar A, Rahman S, Shah U, Adrianzen-Herrera D, Quinn R, Zareef S, Rabinovich E, De Castro A, Joseph F, Gillick K, Mustafa J, Khatun F, Lombardo A, Townsend-Nugent L, Abreu M, Chambers N, Elkind R, Shi Y, Wang Y, Derman O, Gritsman K, Steidl U, Goldfinger M, Kornblum N, Shastri A, Mantzaris I, Bachier-Rodriguez L, Shah N, Cooper D, Verma A, Ye BH, Janakiram M, Sica RA. Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma. Clin Hematol Int. 2023 Jun;5(2-3):78-91. doi: 10.1007/s44228-023-00032-y. Epub 2023 Mar 15. PMID: 36918485; PMCID: PMC10241770.

Vegivinti CTR, Keesari PR, Veeraballi S, Martins Maia CMP, Mehta AK, Lavu RR, Thakur RK, Tella SH, Patel R, Kakumani VK, Pulakurthi YS, Aluri S, Aggarwal RK, Ramachandra N, Zhao R, Sahu S, Shastri A, Verma A. Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review. Exp Hematol Oncol. 2023 Jul 8;12(1):60. doi: 10.1186/s40164-023-00422-1. PMID: 37422676; PMCID: PMC10329313.

Ramachandra N, Gupta M, Schwartz L, Todorova T, Shastri A, Will B, Steidl U, Verma A. Role of IL8 in myeloid malignancies. Leuk Lymphoma. 2023 Jul 19:1-10. doi: 10.1080/10428194.2023.2232492. Epub ahead of print. PMID: 37467070.

Bakouny Z, Labaki C, Grover P, Awosika J, Gulati S, Hsu CY, Alimohamed SI, Bashir B, Berg S, Bilen MA, Bowles D, Castellano C, Desai A, Elkrief A, Eton OE, Fecher LA, Flora D, Galsky MD, Gatti-Mays ME, Gesenhues A, Glover MJ, Gopalakrishnan D, Gupta S, Halfdanarson TR, Hayes-Lattin B, Hendawi M, Hsu E, Hwang C, Jandarov R, Jani C, Johnson DB, Joshi M, Khan H, Khan SA, Knox N, Koshkin VS, Kulkarni AA, Kwon DH, Matar S, McKay RR, Mishra S, Moria FA, Nizam A, Nock NL, Nonato TK, Panasci J, Pomerantz L, Portuguese AJ, Provenzano D, Puc M, Rao YJ, Rhodes TD, Riely GJ, Ripp JJ, Rivera AV, Ruiz-Garcia E, Schmidt AL, Schoenfeld AJ, Schwartz GK, Shah SA, Shaya J, Subbiah S, Tachiki LM, Tucker MD, Valdez-Reyes M, Weissmann LB, Wotman MT, Wulff-Burchfield EM, Xie Z, Yang YJ, Thompson MA, Shah DP, Warner JL, Shyr Y, Choueiri TK, Wise-Draper TM; COVID-19 and Cancer Consortium. Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19. JAMA Oncol. 2023 Jan 1;9(1):128-134. doi: 10.1001/jamaoncol.2022.5357. PMID: 36326731; PMCID: PMC9634600.

Adrianzen-Herrera DA, Sparks AD, Singh R, Alejos Castillo DA, Batra A, Glushakow-Smith SG, Pradhan K, Shastri A, Zakai NA. Impact of Preexisting Autoimmune Disease on Myelodysplastic Syndromes Outcomes: A population Analysis. Blood Adv. 2023 Sep 20:bloodadvances.2023011050. doi: 10.1182/bloodadvances.2023011050. Epub ahead of print. PMID: 37729616.

Wei JX, Shastri A, Sica RA, Mantzaris I, Kornblum N, Shah U, Janakiram M, Gritsman K, Verma A, Goldfinger M, Cooper D, Shah N. Impact of race and ethnicity on early mortality in multiple myeloma: a SEER analysis. Haematologica. 2023 Oct 26. doi: 10.3324/haematol.2023.283304. Epub ahead of print. PMID: 37881838.

Desai SR, Chakraborty S, Shastri A. Mechanisms of resistance to hypomethylating agents and BCL-2 inhibitors. Best Pract Res Clin Haematol. 2023 Dec;36(4):101521. doi: 10.1016/j.beha.2023.101521. Epub 2023 Oct 20. PMID: 38092478.

Garcia-Manero G, McCloskey J, Griffiths EA, Yee KWL, Zeidan AM, Al-Kali A, Deeg HJ, Patel PA, Sabloff M, Keating MM, Zhu N, Gabrail NY, Fazal S, Maly J, Odenike O, Kantarjian H, DeZern AE, O'Connell CL, Roboz GJ, Busque L, Buckstein R, Amin H, Randhawa J, Leber B, Shastri A, Dao KH, Oganesian A, Hao Y, Keer HN, Azab M, Savona MR. Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study. Lancet Haematol. 2024 Jan;11(1):e15-e26. doi: 10.1016/S2352-3026(23)00338-1. PMID: 38135371.

Aminov S, Giricz O, Melnekoff DT, Sica RA, Polishchuk V, Papazoglu C, Yates B, Wang HW, Sahu S, Wang Y, Gordon-Mitchell S, Leshchenko VV, Schinke C, Pradhan K, Aluri S, Sohn M, Barta SK, Agarwal B, Goldfinger M, Mantzaris I, Shastri A, Matsui W, Steidl U, Brody JD, Shah NN, Parekh S, Verma A. Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency. J Clin Invest. 2024 Feb 20:e175199. doi: 10.1172/JCI175199. Epub ahead of print. PMID: 38376944.

Hammami MB, Verceles JA, Goldfinger M, Shah N, Sica RA, Mantzaris I, Kornblum N, Konopleva M, Shastri A, Shapiro LC, Feldman EJ, Gritsman K, Verma A, Cooper DL. Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort. Transplant Cell Ther. 2024 May;30(5):544.e1-544.e8. doi: 10.1016/j.jtct.2024.02.020. Epub 2024 Feb 28. PMID: 38417677

Ben-Crentsil NA, Mohammed Ismail W, Balasis ME, Newman H, Quintana A, Binder M, Kruer T, Neupane S, Ferrall-Fairbanks MC, Fernandez J, Lasho TL, Finke CM, Ibrahim ML, McGraw KL, Wysota M, Aldrich AL, Ryder CB, Letson CT, Traina J, McLemore AF, Droin N, Shastri A, Yun S, Solary E, Sallman DA, Beg AA, Ma L, Gaspar-Maia A, Patnaik MM, Padron E. RNA shielding of P65 is required to potentiate oncogenic inflammation in TET2 mutated clonal hematopoiesis. Cancer Discov. 2024 Aug 27. doi: 10.1158/2159-8290.CD-24-0093. Epub ahead of print. PMID: 39189614

Chakraborty S, Morganti C, Pena BR, Zhang H, Verma D, Zaldana K, Gitego N, Ma F, Aluri S, Pradhan K, Gordon S, Mantzaris I, Goldfinger M, Feldman E, Gritsman K, Shi Y, Hubner S, Qiu YH, Brown BD, Skwarska A, Verma A, Konopleva M, Tabe Y, Gavathiotis E, Colla S, Gollob J, Dey J, Kornblau SM, Koralov SB, Ito K, Shastri A. A STAT3 Degrader Demonstrates Pre-clinical Efficacy in Venetoclax resistant Acute Myeloid Leukemia. bioRxiv [Preprint]. 2024 Aug 7:2024.08.05.599788. doi: 10.1101/2024.08.05.599788. PMID: 39211137; PMCID: PMC11361003

Edema U, Liu J, Ma MY, Krishnamurthy K, Choudhuri J, Li X, Marhatta A, Qi X, Ma IR, Wang Q, Shastri A, Goldfinger M, Gritsman K, Sica RA, Mantzaris I, Kornblum N, Konopleva M, Wang Y, Shi Y. Immunophenotypic, genetic, and clinical characterization of adult T-cell leukemia/lymphoma: A single tertiary care center experience in the United States. Am J Clin Pathol. 2024 Aug 30:aqae111. doi: 10.1093/ajcp/aqae111. Epub ahead of print. PMID: 39212661

Goldfinger M, Mantzaris I, Shastri A, Saunthararajah Y, Gritsman K, Sica A, Kornblum N, Shah N, Levitz D, Rockwell B, Shapiro LC, Gupta R, Pradhan K, Xue X, Munoz A, Dhawan A, Fehn K, Comas M, Verceles JA, Jonas BA, Kambhampati S, Shi Y, Braunschweig I, Cooper DL, Konopleva MY, Feldman EJ, Verma A. A Weekly Low-Dose Regimen of Decitabine and Venetoclax is Efficacious and Less Myelotoxic in a Racially Diverse Cohort. Blood. 2024 Sep 24:blood.2024025834. doi: 10.1182/blood.2024025834. Epub ahead of print. PMID: 39316768.